Clinical Ink
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.
Digital Artefacts
Acquisition in 2021
Digital Artefacts is a technology company that focuses on developing innovative solutions in web and mobile applications, as well as in the fields of Internet of Things (IoT), wearable electronics, and virtual/augmented reality (VR/AR). Additionally, the company creates advanced 3D modeling and time visualization software specifically tailored for the healthcare sector. Their platform facilitates decentralized clinical studies by providing cognitive, behavioral, and physiological data, which supports extensive research into autoimmune, oncology, and respiratory disorders. By utilizing diverse methodologies such as voice, movement, and mood analysis, Digital Artefacts aims to enhance the understanding and treatment of various health conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.